InvestorsHub Logo
Post# of 252977
Next 10
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

Re: biocqr post# 176360

Thursday, 04/03/2014 9:47:33 PM

Thursday, April 03, 2014 9:47:33 PM

Post# of 252977
So Stemcell is not all that far behind Weissman, and based on their upcoming AACR presentation they potentially have some advantages .

For this sort of new biology, going second isn't bad at all.

Peter
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.